View Clinical Trial (Medical Research Study)

A Phase 2 Study of BTA798 in Asthmatic Adults With Symptomatic Human Rhinovirus Infection - NCT01175226-43560(Clinical Trial 721383)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup
City:  Sylvania
State:  
OH
Zip Code: 43560
Conditions: Rhinovirus
Purpose: This study aims to evaluate the safety, tolerability and effectiveness of BTA798 on - shortening the length and reducing the symptoms of human rhinovirus infection (also known as the common cold), - controlling asthma symptoms, and - lowering the risk of asthma symptoms worsening in subjects with asthma.
Study summary: Subjects with a previous diagnosis of asthma will be pre screened within 90 days prior to enrolment. If a subject develops symptoms of HRV infection they will visit the site for assessment. Symptomatic subjects meeting all eligibility criteria will be invited to enroll.
Criteria: Inclusion Criteria: - Male and female subjects aged 18-70 years - Diagnosis of asthma consistent with GINA steps 1 to 3 - Presumptive human rhinovirus infection Exclusion Criteria: - Current severe asthma exacerbation - Severe asthma, GINA steps 4 or higher - Uncontrolled or clinically significant medical condition, disease or event which could impact subject safety and/or study evaluations and/or compliance to the protocol - Current smoker, ex-smoker of <1 year, or history of smoking >/=10 pack years.
Study is available at: Research Site
Sylvania, OH 43560
United States

Primary Contact:
Contact Person
Email: Email@Email.com
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.
Data Source: ClinicalTrials.gov
Date Processed: March 23, 2011
Modifications to
this listing:		 Only selected fields are shown, please use the link above to view all information about this clinical trial.